117 related articles for article (PubMed ID: 22578959)
1. PAR2 knock-out C57Bl6 mice as a model for evaluating metastases of cancer cells: pilot in vivo study of the metastatic potential of B16 melanoma in knock-out (PAR2-/-) animals.
Matěj R; Zadinová M; Poučková P; Kukal J; Olejár T
Folia Biol (Praha); 2012; 58(2):81-6. PubMed ID: 22578959
[TBL] [Abstract][Full Text] [Related]
2. Dual role of host Par2 in a murine model of spontaneous metastatic B16 melanoma.
Olejar T; Vetvicka D; Zadinova M; Pouckova P; Kukal J; Jezek P; Matej R
Anticancer Res; 2014 Jul; 34(7):3511-5. PubMed ID: 24982362
[TBL] [Abstract][Full Text] [Related]
3. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
5. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.
Camerer E; Qazi AA; Duong DN; Cornelissen I; Advincula R; Coughlin SR
Blood; 2004 Jul; 104(2):397-401. PubMed ID: 15031212
[TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma.
Yudoh K; Matsuno H; Kimura T
J Lab Clin Med; 1999 Feb; 133(2):120-8. PubMed ID: 9989763
[TBL] [Abstract][Full Text] [Related]
7. Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease.
Afkhami-Goli A; Noorbakhsh F; Keller AJ; Vergnolle N; Westaway D; Jhamandas JH; Andrade-Gordon P; Hollenberg MD; Arab H; Dyck RH; Power C
J Immunol; 2007 Oct; 179(8):5493-503. PubMed ID: 17911636
[TBL] [Abstract][Full Text] [Related]
8. Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice.
Thies A; Mauer S; Fodstad O; Schumacher U
Br J Cancer; 2007 Feb; 96(4):609-16. PubMed ID: 17262079
[TBL] [Abstract][Full Text] [Related]
9. Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b.
Yang L; Ma Y; Han W; Li W; Cui L; Zhao X; Tian Y; Zhou Z; Wang W; Wang H
J Biol Chem; 2015 Oct; 290(44):26627-37. PubMed ID: 26354435
[TBL] [Abstract][Full Text] [Related]
10. Role of protease-activated receptor 2 in regulation of renin synthesis and secretion in mice.
Thurner LR; Höcherl K
Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1401-1410. PubMed ID: 31243492
[TBL] [Abstract][Full Text] [Related]
11. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of protease-activated receptor-2 (PAR
He S; Xu M; Xiong Z; Hu Y; Huo Q; Lu J; Lin Y; Yang L
J Cell Mol Med; 2021 Feb; 25(3):1415-1424. PubMed ID: 33369107
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
[TBL] [Abstract][Full Text] [Related]
14. Perivascular adipose tissue-derived relaxing factors: release by peptide agonists via proteinase-activated receptor-2 (PAR2) and non-PAR2 mechanisms.
Li Y; Mihara K; Saifeddine M; Krawetz A; Lau DC; Li H; Ding H; Triggle CR; Hollenberg MD
Br J Pharmacol; 2011 Dec; 164(8):1990-2002. PubMed ID: 21615723
[TBL] [Abstract][Full Text] [Related]
15. Proteinase-activated receptor-2 (PAR2): a tumor suppressor in skin carcinogenesis.
Rattenholl A; Seeliger S; Buddenkotte J; Schön M; Schön MP; Ständer S; Vergnolle N; Steinhoff M
J Invest Dermatol; 2007 Sep; 127(9):2245-52. PubMed ID: 17476297
[TBL] [Abstract][Full Text] [Related]
16. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
[TBL] [Abstract][Full Text] [Related]
17. Metastatic variants of the B16 melanoma: metastasis is related to environmental conditions. Phenotypic changes in vitro and metastatic colonization potential in nude mice.
Aubert C
Melanoma Res; 1995 Jun; 5(3):139-46. PubMed ID: 7640514
[TBL] [Abstract][Full Text] [Related]
18. Deletion of protease-activated receptor 2 prolongs survival of scrapie-inoculated mice.
Matej R; Olejar T; Janouskova O; Holada K
J Gen Virol; 2012 Sep; 93(Pt 9):2057-2061. PubMed ID: 22694901
[TBL] [Abstract][Full Text] [Related]
19. The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells.
Zhou H; Hu H; Shi W; Ling S; Wang T; Wang H
Oncol Rep; 2008 Nov; 20(5):1069-76. PubMed ID: 18949403
[TBL] [Abstract][Full Text] [Related]
20. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
Zeeh F; Witte D; Gädeken T; Rauch BH; Grage-Griebenow E; Leinung N; Fromm SJ; Stölting S; Mihara K; Kaufmann R; Settmacher U; Lehnert H; Hollenberg MD; Ungefroren H
Oncotarget; 2016 Jul; 7(27):41095-41109. PubMed ID: 27248167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
